Tumor-Killing Liquid Offers A Safer "Bridge" Therapy for Patients with Liver Cancer (1 of 3) (IMAGE)
Caption
MicroCT images and 3D renderings of tumors in the livers of rats two weeks after receiving either saline (left), ethanol (middle), or LATTE (right). This material relates to a paper that appeared in the Jan. 20, 2021, issue of <i>Science Translational Medicine</i>, published by AAAS. The paper, by H. Albadawi at Mayo Clinic in Phoenix, AZ; and colleagues was titled, "Percutaneous liquid ablation agent for tumor treatment and drug delivery."
Credit
[Credit: H. Albadawi <i>et al., Science Translational Medicine</i> (2021)]
Usage Restrictions
Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.
License
Licensed content